Viewing Study NCT00875433


Ignite Creation Date: 2025-12-25 @ 2:50 AM
Ignite Modification Date: 2026-03-06 @ 2:40 AM
Study NCT ID: NCT00875433
Status: COMPLETED
Last Update Posted: 2013-12-30
First Post: 2009-04-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Afatinib (BIBW 2992) QTcF Trial in Patients With Relapsed or Refractory Solid Tumours
Sponsor: Boehringer Ingelheim
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
Keywords: